These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 34302713)

  • 41. Philadelphia Chromosome in an Infant With Pro-B Acute Lymphoblastic Leukemia.
    Das A; Bansal D; Sreedharanunni S; Naseem S
    J Pediatr Hematol Oncol; 2017 Jan; 39(1):79-80. PubMed ID: 27820127
    [No Abstract]   [Full Text] [Related]  

  • 42. Mucoepidermoid carcinoma of the parotid gland in a child previously treated for acute lymphoblastic leukemia.
    Boccon-Gibod L; Boman F; Josset P; Landman-Parker J
    Pediatr Blood Cancer; 2005 Jun; 44(7):673-5. PubMed ID: 15515042
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Concurrent treatment of steroid-related mood and psychotic symptoms with risperidone.
    Ularntinon S; Tzuang D; Dahl G; Shaw RJ
    Pediatrics; 2010 May; 125(5):e1241-5. PubMed ID: 20385646
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A Systematic Review of Blinatumomab in the Treatment of Acute Lymphoblastic Leukemia: Engaging an Old Problem With New Solutions.
    Halford Z; Coalter C; Gresham V; Brown T
    Ann Pharmacother; 2021 Oct; 55(10):1236-1253. PubMed ID: 33435716
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CD123 expression patterns and selective targeting with a CD123-targeted antibody-drug conjugate (IMGN632) in acute lymphoblastic leukemia.
    Angelova E; Audette C; Kovtun Y; Daver N; Wang SA; Pierce S; Konoplev SN; Khogeer H; Jorgensen JL; Konopleva M; Zweidler-McKay PA; Medeiros LJ; Kantarjian HM; Jabbour EJ; Khoury JD
    Haematologica; 2019 Apr; 104(4):749-755. PubMed ID: 30361418
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Overexpression of CD49f in precursor B-cell acute lymphoblastic leukemia: potential usefulness in minimal residual disease detection.
    DiGiuseppe JA; Fuller SG; Borowitz MJ
    Cytometry B Clin Cytom; 2009 Mar; 76(2):150-5. PubMed ID: 18831072
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prognostic importance of the pre-B-cell immunophenotype and other presenting features in B-lineage childhood acute lymphoblastic leukemia: a Pediatric Oncology Group study.
    Crist W; Boyett J; Jackson J; Vietti T; Borowitz M; Chauvenet A; Winick N; Ragab A; Mahoney D; Head D
    Blood; 1989 Sep; 74(4):1252-9. PubMed ID: 2669998
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Inflammatory mediator ultra-low-molecular-weight hyaluronan triggers necrosis of B-precursor leukemia cells with high surface CD44 expression.
    Kasai S; Furuichi Y; Ando N; Kagami K; Abe M; Nakane T; Goi K; Inukai T; Saitoh S; Ohno S; Okazaki S; Nagano O; Saya H; Sugita K
    Cell Death Dis; 2017 Jun; 8(6):e2857. PubMed ID: 28569787
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Low relapse rate in children with acute lymphoblastic leukemia after risk-directed therapy.
    Tzortzatou-Stathopoulou F; Papadopoulou AL; Moschovi M; Botsonis A; Tsangaris GT
    J Pediatr Hematol Oncol; 2001 Dec; 23(9):591-7. PubMed ID: 11902303
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Redefining clinical risk classification in children with precursor B cell acute lymphoblastic leukemia using pre-treatment absolute lymphocyte count.
    Fungpipat P; Sophonphan J; Sosothikul D; Suppipat K
    Leuk Lymphoma; 2016; 57(4):953-6. PubMed ID: 26292611
    [No Abstract]   [Full Text] [Related]  

  • 51. Therapeutic potential of spleen tyrosine kinase inhibition for treating high-risk precursor B cell acute lymphoblastic leukemia.
    Perova T; Grandal I; Nutter LM; Papp E; Matei IR; Beyene J; Kowalski PE; Hitzler JK; Minden MD; Guidos CJ; Danska JS
    Sci Transl Med; 2014 May; 6(236):236ra62. PubMed ID: 24828076
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Prediction of outcome by early response in childhood acute lymphoblastic leukemia.
    Möricke A; Lauten M; Beier R; Odenwald E; Stanulla M; Zimmermann M; Attarbaschi A; Niggli F; Schrappe M
    Klin Padiatr; 2013 May; 225 Suppl 1():S50-6. PubMed ID: 23700057
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Combined analysis of minimal residual disease at two time points and its value for risk stratification in childhood B-lineage acute lymphoblastic leukemia.
    Cui L; Li Z; Wu M; Li W; Gao C; Deng G
    Leuk Res; 2010 Oct; 34(10):1314-9. PubMed ID: 20034668
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Serum alpha tocopherol, vitamin B12, and folate levels in childhood acute lymphoblastic leukemia survivors with and without neuropathy.
    Jain P; Gulati S; Toteja GS; Bakhshi S; Seth R; Pandey RM
    J Child Neurol; 2015 May; 30(6):786-8. PubMed ID: 24859786
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Up-regulation of asparagine synthetase expression is not linked to the clinical response L-asparaginase in pediatric acute lymphoblastic leukemia.
    Appel IM; den Boer ML; Meijerink JP; Veerman AJ; Reniers NC; Pieters R
    Blood; 2006 Jun; 107(11):4244-9. PubMed ID: 16497975
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Vitamin D protects acute lymphoblastic leukemia cells from dexamethasone.
    Antony R; Sheng X; Ehsanipour EA; Ng E; Pramanik R; Klemm L; Ichihara B; Mittelman SD
    Leuk Res; 2012 May; 36(5):591-3. PubMed ID: 22341429
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Clinical relevance of CD10 expression in childhood ALL. The Italian Association for Pediatric Hematology and Oncology (AIEOP).
    Consolini R; Legitimo A; Rondelli R; Guguelmi C; Barisone E; Lippi A; Cantù-Rajnoldi A; Aricò M; Conter V; Cocito MG; Putti MC; Pession A; Masera G; Biondi A; Basso G
    Haematologica; 1998 Nov; 83(11):967-73. PubMed ID: 9864914
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Use of clinical and laboratory features to define prognostic subgroups in B-precursor acute lymphoblastic leukemia: experience of the Pediatric Oncology Group.
    Borowitz MJ; Carroll AJ; Shuster JJ; Look AT; Behm FG; Pullen DJ; Land VJ; Steuber P; Crist WM
    Recent Results Cancer Res; 1993; 131():257-67. PubMed ID: 8210645
    [No Abstract]   [Full Text] [Related]  

  • 59. Immunohistochemical distinction of haematogones from B lymphoblastic leukaemia/lymphoma or B-cell acute lymphoblastic leukaemia (B-ALL) on bone marrow trephine biopsies: a study on 62 patients.
    Al-Shieban S; Byrne E; Trivedi P; Morilla R; Matutes E; Naresh KN
    Br J Haematol; 2011 Aug; 154(4):466-70. PubMed ID: 21722099
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Precursor B-cell acute lymphoblastic leukemia presenting with hemophagocytic lymphohistiocytosis.
    O'Brien MM; Lee-Kim Y; George TI; McClain KL; Twist CJ; Jeng M
    Pediatr Blood Cancer; 2008 Feb; 50(2):381-3. PubMed ID: 16856156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.